Table 2.
Clinical characteristics of patients with Zika virus infection in intensive care.
| Patients | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ICU characterization | |||||||||||
| Mean APACHE II (standard deviation) | 12 ± 7 | ||||||||||
| Reason for ICU admission — no (%) | |||||||||||
| Risk of respiratory insufficiency caused by neuromuscular weakness | 6 (60) | + | + | + | + | + | + | ||||
| Progressive neurological deterioration (motor/sensitive) | 0 (0) | + | |||||||||
| Mental status compromise | 3 (30) | + | |||||||||
| Other (septic shock/thrombocytopenia) | 1 (10) | + | + | ||||||||
| Indicators of stay. Median-IQR (days) | |||||||||||
| Time: Begging of symptoms-ICU admission | 5.5 (9–2) | 1 | 0 | 18 | 4 | 6 | 2 | 8 | 5 | 22 | 9 |
| Time: Hospital stay | 13 (14–3) | 36 | 3 | 10 | 9 | 14 | 25 | 7 | 9 | 11 | 10 |
| Time: ICU stay | 6.5 (9–6) | 0 | 3 | 6 | 6 | 16 | 27 | 7 | 9 | 9 | 6 |
| Time: Begging of symptoms − Neurological nadir | 6 (8–4) | 4 | 3 | 7 | 8 | 5 | 8 | 14 | 5 | ||
| Rankin at discharge | 1 (6–1) | 5 | 1 | 1 | 6 | 6 | 1 | 1 | |||
| Hemodynamic support n (%) | |||||||||||
| Need for ventilatory support | 6 (60) | + | + | + | + | + | + | ||||
| Need for hemodynamic support | 4 (40) | + | + | + | + | ||||||
| Plasmapheresis | 1 (10) | + | |||||||||
| Immunoglobulins | 6 (60) | + | + | + | + | + | + | ||||
PCR: Polymerase Chain Reaction, IgM: Immunoglobulin M, APACHE = acute physiology and chronic health examination, ICU: Intensive Care Unit, IQR: Interquartile range.